Catalent Pharma Solutions Licenses Innovative Taste-Masking Technology for Bitter Drugs Following R&D Collaboration With New Jersey Institute of Technology (NJIT)

Published: Oct 10, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Following a successful research collaboration, Catalent Pharma Solutions announces that it has taken an exclusive license to innovative taste-masking technology developed by the New Jersey Institute of Technology (NJIT). The technology has been developed to mask the most challenging, unpleasant and bitter tasting pharmaceutical active ingredients.

Back to news